Pterostilbene
Also known as: PTE, PT, trans-pterostilbene, 3,5-dimethoxy-4'-hydroxystilbene, resveratrol analog
Effective Dosage
10-200 mg daily (human safety established; optimal therapeutic dose unclear)
What the Science Says
Pterostilbene is a natural polyphenol found in blueberries and grapes, and a close chemical cousin of resveratrol — but with better absorption and metabolic stability. In human trials, it has been studied mostly in combination with nicotinamide riboside (NR), where the pair showed modest reductions in liver enzyme markers (ALT and GGT) in people with fatty liver disease, and helped raise NAD+ levels in patients with acute kidney injury. Short-term use at doses of 10–200 mg/day appears safe with no reported adverse events, but most exciting findings — anti-cancer, anti-inflammatory, joint protection — come from lab and animal studies, not human trials.
What It Doesn't Do
Won't cure or treat cancer in humans — all anti-tumor data is from cell lines and mice. Not proven to build or repair muscle — a clinical trial found no benefit for muscle recovery in elderly people. Doesn't reliably reduce body fat in humans — the obesity data is from rats. Not a proven treatment for fatty liver disease — it failed to reduce liver fat in the primary endpoint of its NAFLD trial. Don't assume it works like resveratrol just because they're similar — human evidence for both is thin.
Evidence-Based Benefits
Pterostilbene is a natural polyphenol found in blueberries and grapes, and a close chemical cousin of resveratrol — but with better absorption and metabolic stability. In human trials, it has been studied mostly in combination with nicotinamide riboside (NR), where the pair showed modest reductions in liver enzyme markers (ALT and GGT) in people with fatty liver disease, and helped raise NAD+ levels in patients with acute kidney injury. Short-term use at doses of 10–200 mg/day appears safe with no reported adverse events, but most exciting findings — anti-cancer, anti-inflammatory, joint protection — come from lab and animal studies, not human trials.
Weak EvidenceEffective at: 10-200 mg daily (human safety established; optimal therapeutic dose unclear)
Source: auto-research
Absorption & Bioavailability
Good relative to resveratrol — pterostilbene's methoxy groups improve lipid solubility and metabolic stability, which is why it's often marketed as a 'better resveratrol.' However, human pharmacokinetic data from the provided studies is limited.
Red Flags to Watch For
- Most exciting benefits (anti-cancer, cardioprotection, joint health) are from lab and animal studies only — not proven in humans
- Human trials have mostly tested pterostilbene in combination with nicotinamide riboside (NR), making it impossible to isolate pterostilbene's individual contribution
- The NAFLD trial failed its primary endpoint (liver fat reduction) — a key marketing claim is not supported
- Optimal human dose is unknown — studies used widely varying doses with no clear dose-response relationship established
- Over 1,000 supplement products contain it despite very limited standalone human clinical evidence
Products Containing Pterostilbene
See how Pterostilbene is used in these analyzed products:
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-08